UA108058C2 - Кристалічний d-ізоглутаміл-d-триптофан і моноамонійна сіль d-ізоглутаміл-d-триптофану - Google Patents

Кристалічний d-ізоглутаміл-d-триптофан і моноамонійна сіль d-ізоглутаміл-d-триптофану

Info

Publication number
UA108058C2
UA108058C2 UAA200906634A UAA200906634A UA108058C2 UA 108058 C2 UA108058 C2 UA 108058C2 UA A200906634 A UAA200906634 A UA A200906634A UA A200906634 A UAA200906634 A UA A200906634A UA 108058 C2 UA108058 C2 UA 108058C2
Authority
UA
Ukraine
Prior art keywords
isoglutamil
tryptophane
ammonium salt
crystalline
mono
Prior art date
Application number
UAA200906634A
Other languages
English (en)
Russian (ru)
Inventor
Тім Фет Там
Блейз Н'земба
Рейс Леунг-Тоунг
Йінгсхенг Ванг
Йанквінг Жао
Лілі Иу
Original Assignee
Апотекс Технолоджис Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Апотекс Технолоджис Інк. filed Critical Апотекс Технолоджис Інк.
Publication of UA108058C2 publication Critical patent/UA108058C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Винахід належить до кристалічного D-ізоглутаміл-D-триптофану та його кристалічної амонійної солі H-D-iGlu-D-Trp-OH. Також винахід розкриває спосіб одержання у водній фазі D-ізоглутаміл-D-триптофану, вільного від неорганічних солей, та спосіб одержання моноамонійної солі H-D-iGlu-D-Trp-OH, вільної від неорганічних солей. Винахід належить також до фармацевтичної композиції, що містить кристалічну амонійну сіль H-D-iGlu-D-Trp-OH, та її застосування як засобу проти псоріазу та як імуносупресанта.
UAA200906634A 2006-11-28 2007-11-26 Кристалічний d-ізоглутаміл-d-триптофан і моноамонійна сіль d-ізоглутаміл-d-триптофану UA108058C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002569204A CA2569204A1 (en) 2006-11-28 2006-11-28 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
PCT/CA2007/002123 WO2008064465A1 (en) 2006-11-28 2007-11-26 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan

Publications (1)

Publication Number Publication Date
UA108058C2 true UA108058C2 (uk) 2015-03-25

Family

ID=39467380

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200906634A UA108058C2 (uk) 2006-11-28 2007-11-26 Кристалічний d-ізоглутаміл-d-триптофан і моноамонійна сіль d-ізоглутаміл-d-триптофану

Country Status (9)

Country Link
US (3) US8119606B2 (uk)
EP (1) EP2121728A4 (uk)
KR (1) KR20090085127A (uk)
CN (4) CN103288704A (uk)
AU (1) AU2007327344B2 (uk)
CA (2) CA2569204A1 (uk)
MX (1) MX2009005664A (uk)
UA (1) UA108058C2 (uk)
WO (1) WO2008064465A1 (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120157387A1 (en) * 2006-11-28 2012-06-21 Apotex Technologies Inc. Orally bioavailable d-gamma-glutamyl-d-tryptophan
CA2571645A1 (en) * 2006-12-19 2008-06-19 Apotex Technologies Inc. Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
CA2579119C (en) 2007-02-16 2013-03-05 Apotex Technologies Inc. Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
JP2014509613A (ja) * 2011-03-31 2014-04-21 アポテックス テクノロジーズ インコーポレイテッド Ｄ−イソグルタミル−［ｄ／ｌ］−トリプトファンのプロドラッグ
CA2831429A1 (en) * 2011-03-31 2012-10-04 Apotex Technologies Inc. Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
CN102417474B (zh) * 2011-09-26 2014-07-02 深圳翰宇药业股份有限公司 D-异谷氨酰基-d-色氨酸制备的新方法
CN102603609B (zh) * 2012-02-10 2014-02-05 深圳翰宇药业股份有限公司 一种合成d-异谷氨酰胺-d-色氨酸的方法
WO2013123574A1 (en) * 2012-02-20 2013-08-29 Apotex Technologies Inc. Orally bioavailable derivatives of d-gamma-glutamyl-d-tryptophan
WO2013155592A1 (en) * 2012-04-18 2013-10-24 Apotex Technologies Inc. Crystal forms of golotimod and process for its manufacturing
WO2013155595A1 (en) * 2012-04-18 2013-10-24 Apotex Technologies Inc. Process for the preparation of a monosodium salt of h-d-glu-(l-trp-oh)-oh and a crystalline form thereof
WO2017019175A1 (en) 2015-07-24 2017-02-02 Newlink Genetics Corporation Salts and prodrugs of 1-methyl-d-tryptophan
CN110031583B (zh) * 2018-12-29 2022-01-18 浙江工业大学 分离测定n-琥珀酰色氨酸对映异构体的液相色谱方法
RU2703991C1 (ru) * 2019-02-12 2019-10-23 Акционерное общество "Медико-биологический научно-производственный комплекс "Цитомед" (АО "МБНПК "Цитомед") Способ получения мононатриевой соли изоглутамил-триптофана

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566747B2 (en) 1984-01-10 1987-10-29 Mitsui Chemicals, Inc. Method of separating l-tryptophan
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
RU2107692C1 (ru) * 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US6103699A (en) * 1996-06-07 2000-08-15 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US5744452A (en) 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
IL120923A0 (en) 1997-05-27 1997-09-30 Amylum Nv A combined process for the production of lysine and its salts and of a further weak acid and a salt thereof

Also Published As

Publication number Publication date
CN103288706A (zh) 2013-09-11
CA2569204A1 (en) 2008-05-28
CN103288704A (zh) 2013-09-11
AU2007327344B2 (en) 2013-09-12
WO2008064465B1 (en) 2008-07-24
WO2008064465A1 (en) 2008-06-05
US8507449B2 (en) 2013-08-13
EP2121728A4 (en) 2011-01-19
US20130060048A1 (en) 2013-03-07
RU2009124490A (ru) 2011-01-10
US8476235B2 (en) 2013-07-02
CN101605806B (zh) 2014-03-12
KR20090085127A (ko) 2009-08-06
US20100016243A1 (en) 2010-01-21
US8119606B2 (en) 2012-02-21
AU2007327344A1 (en) 2008-06-05
MX2009005664A (es) 2009-10-12
CN103288705A (zh) 2013-09-11
CA2672369A1 (en) 2008-06-05
EP2121728A1 (en) 2009-11-25
CN101605806A (zh) 2009-12-16
US20130059791A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
UA108058C2 (uk) Кристалічний d-ізоглутаміл-d-триптофан і моноамонійна сіль d-ізоглутаміл-d-триптофану
GEP20156243B (en) Fused heteroaromatic pyrrolidinones as syk inhibitors
WO2010003133A3 (en) Cdk modulators
EP2536736A4 (en) PREPARATION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATE PRODUCTS THEREOF
MY171577A (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
UA108623C2 (uk) Низьколеткі амінні солі аніонних пестицидів
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
WO2010032875A3 (en) Heterocyclic carboxamide compounds
MA33838B1 (fr) Forme amorphe et cristalline de l'hémitartrate de genz 112638 au titre d'inhibiteur de la glucosylcéramide synthétase
NZ594738A (en) Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
WO2007042321A3 (en) Kinase inhibitors
WO2012162254A8 (en) Inhibitors of lrrk2 kinase activity
SI2176253T1 (sl) Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila
PL1981829T3 (pl) Kompozycje zawierające sole podwójne azotanu amonu
NZ606366A (en) Stabilization of fsh
MX2008010884A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
ZA200904543B (en) Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation
WO2009094560A3 (en) Thienopyranones as kinase inhibitors
WO2009126861A3 (en) Triazolopyridine compounds useful as dgat1 inhibitors
ZA201100535B (en) Salts,aqueous liquid compositions containing salts of s-(+)-abscisic acid and methods of their preparation
IL195632A0 (en) Substituted carboxamides
WO2010013835A3 (en) Solid pharmaceutical composition
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
MX2010002649A (es) Composicion cosmetica para administracion topica en forma de spray.
EP2575465A4 (en) Raltegravir SALTS